Monique Hartley-Brown, MD
Hematology · Boston, MANPI 1992904387
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $38,251 of the $46,906 with a category attached, or 81.5%. It is spread thinly across 13 manufacturers, the largest accounting for just 21.1%. Reporting peaked in 2022 at $15,914 and has fallen 68.1% since, to $5,073 in 2025.
Across 74 payments — averaging $633.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$10K
- E.r. Squibb & Sons, L.L.C.$9K
- Sanofi$8K
- Pfizer$8K
- GSK$5K
- Bristol Myers Squibb$4K
- plus $3K from 7 others
Across 48 payments — averaging $107,587 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bristol Myers Squibb$4M
- E.r. Squibb & Sons, L.L.C.$1M
- AstraZeneca$67K
- Janssen Research & Development, LLC$62K
- Pfizer$35K
- Acerta Pharma LLC$25K
- plus $1K from 1 others
What the payments were for
- Consulting fees$38,25182%
- Speaking & faculty fees$3,2957%
- Travel & lodging$2,0174%
- Food & beverage$3,0837%
- Education$2601%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 20 | $9,921 |
| E.r. Squibb & Sons, L.L.C. | 12 | $9,333 |
| Sanofi | 13 | $7,969 |
| Pfizer | 8 | $7,752 |
| GSK | 2 | $5,000 |
| Bristol Myers Squibb | 4 | $3,616 |
| Karyopharm Therapeutics Inc. | 4 | $2,657 |
| AstraZeneca | 3 | $339 |
| Taiho Oncology, Inc. | 3 | $136 |
| Braeburn Inc. | 1 | $125 |
| Novartis | 1 | $21 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $19 |
| Janssen Scientific Affairs, LLC | 2 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$46,906 in reported general payments places this provider in the 80th percentile of 77 hematology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology in Boston
- Edward BenzBoston$747K
- David KuterBoston$543K
- Jacalyn RosenblattBoston$455K
- Lynn BryBoston$286K
- John SloanBoston$257K
- Andrew EvensBoston$217K
- Omar NadeemBoston$191K
- Nathan ConnellBoston$145K
- Jean ConnorsBoston$144K
- Heather BenjaminBoston$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.